0001209191-20-045939.txt : 20200810 0001209191-20-045939.hdr.sgml : 20200810 20200810162226 ACCESSION NUMBER: 0001209191-20-045939 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200806 FILED AS OF DATE: 20200810 DATE AS OF CHANGE: 20200810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parini Michael CENTRAL INDEX KEY: 0001661567 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 201089673 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-06 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001661567 Parini Michael C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Chief Adm, Leg & BD Off Common Stock 2020-08-06 4 M 0 1223 155.57 A 28061 D Common Stock 2020-08-06 4 S 0 490 270.13 D 27571 D Common Stock 2020-08-06 4 S 0 422 271.45 D 27149 D Common Stock 2020-08-06 4 S 0 311 272.53 D 26838 D Stock Option (Right to Buy) 155.57 2020-08-06 4 M 0 1223 0.00 D 2028-02-05 Common Stock 1223 7338 D Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $270.13 (range $269.73 to $270.59). Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $271.45 (range $270.94 to $271.88). Open market sales reported on this line occurred at a weighted average price of $272.53 (range $272.16 to $272.86). The option vests in 16 quarterly installments from 02/06/2018. /s/ Sabrina Yohai, Attorney-in-Fact 2020-08-10